Submitted by Anonymous (not verified) on 30 January 2026 - 14:32
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 27, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Kisplyx, lenvatinib, Date of authorisation: 25/08/2016, Revision: 27, Status: Authorised